Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Julián Núñez(Instituto de Salud Carlos III), Inmaculada Jarrín(Instituto de Salud Carlos III), Juan Berenguer(Instituto de Salud Carlos III), Enrique Bernal(Honeywell (United States)), Luís Metola(Transparency International), Juan González‐García(Hospital Universitario La Paz), Julia del Amo(Transparency International), María Jesús Vivancos(Hospital Universitario Ramón y Cajal), Gemma Navarro(Deleted Institution), J A Iribarren Loyarte(Transparency International)
Cited by 17
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Autologous hematopoietic stem cell transplantation in multiple sclerosis
|Neurology|2015|247